Seminars in Oncology
Volume 33, Supplement 11 , Pages 28-32, December 2006

Planned Treatment Interruptions and Chemotherapy-Free Intervals in the Treatment of Metastatic Colorectal Cancer: Time to Start Stopping?

  • Leonard Saltz

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Leonard Saltz, MD, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021.

Gastrointestinal Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr Saltz has served as a paid consultant to Pfizer, Sanofi-Aventis, and Amgen. He has received research grant support from Bristol-Myers Squibb, Pfizer, Imclone, Genentech, and Roche.

PII: S0093-7754(06)00386-1

doi:10.1053/j.seminoncol.2006.10.009

Seminars in Oncology
Volume 33, Supplement 11 , Pages 28-32, December 2006

Article Tools

* Image Usage & Resolution